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Aim To determine whether maternal leptin (LEP) and lep-
tin receptor (LEPR) gene polymorphisms are associated 
with idiopathic recurrent spontaneous abortion (IRSA).
Methods This case-control association study conducted 
from 2010 to 2012 at the Department of Gynecology and 
Obstetrics, University Hospital Center Osijek and Clinical In-
stitute of Medical Genetics Ljubljana included 178 women 
with a history of three or more IRSAs before the 22nd week 
of gestation and 145 women with at least two live births 
and no history of pathologic pregnancies during repro-
ductive period. Polymorphisms of maternal LEP (rs7799039, 
rs2122627, rs11761556, rs10244329) and LEPR (rs1137101, 
rs7516341, rs1186403, rs12062820) were assessed by allele 
specific real-time polymerase chain reaction. Genotype 
distribution, allele frequencies, and frequency of haplo-
types at LEP and LEPR genetic loci were determined.
Results We observed more frequent genotype for 
rs7516341 (nominal P = 0.034, odds ratio [OR] 0.61, 95% 
confidence interval [CI] 0.38-0.97) and rs1137101 (nomi-
nal P = 0.048, OR 1.66, 95% CI 1.00-2.80) in the LEPR gene in 
patients than in controls, but these results did not remain 
significant after correction for multiple testing according 
to Bonferroni (adjusted P value threshold was set at 0.05). 
We did not observe differential distribution of genotype 
frequencies in the LEP gene between cases and controls. In 
patients with IRSA, GTCC haplotype in the LEPR gene locus 
was significantly less frequent than in controls (P = 0.00865, 
OR 0.45), contrary to ACTC haplotype (P = 0.0087, OR 1.98).
Conclusions We showed that genetic variability in the 
LEPR gene was associated with IRSA, warranting confirma-
tion on a greater number of patients and pathogenesis in-
vestigation.
Received: June 30, 2016
Accepted: December 15, 2016
Correspondence to: 
Borut Peterlin 
Clinical Institute of Medical 
Genetics 
Division of Obstetrics and 
Gynecology 
University Medical Center Ljubljana 
Zaloška cesta 7 
1000 Ljubljana, Slovenia 
borut.peterlin@guest.arnes.si
Andrijana Müller1,5, Jasenka 
Wagner2, Alenka Hodžić3, 
Aleš Maver3, Ivana Škrlec2, 
Marija Heffer2, Lada Zibar4,5, 
Borut Peterlin3
1Department of Gynecology and 
Obstetrics, University Hospital 
Center Osijek, Osijek, Croatia
2Department of Medical Biology 
and Genetics, Faculty of Medicine, 
Josip Juraj Strossmayer University 
of Osijek, Osijek, Croatia
3Clinical Institute of Medical 
Genetics, Division of Obstetrics 
and Gynecology, University 
Medical Center Ljubljana, Ljubljana, 
Slovenia
4Department for Dialysis, Internal 
Clinic, University Hospital Center 
Osijek, Osijek, Croatia
5Faculty of Medicine, Josip Juraj 
Strossmayer University of Osijek, 
Osijek, Croatia
Genetic variation in leptin and 
leptin receptor genes is a risk 




Croat Med J. 2016;57:566-71 
https://doi.org/10.3325/cmj.2016.57.566
567Müller et al: Leptin genetic variations and idiopathic recurrent spontaneous abortion
www.cmj.hr
Recurrent spontaneous abortion (RSA) is a spontaneous 
loss of three or more pregnancies before the 22nd week 
of gestation. It affects approximately 0.5%-3% of women 
and can be caused by several factors (1). However, about 
50% of the cases remain unexplained and classified as id-
iopathic (IRSA) (2).
Among the factors that raise the risk of several pregnancy 
complications, including the risk of recurrent miscarriage, is 
obesity (3). One of the mechanisms involved in obesity is as-
sociated with mutations in leptin signaling pathway; muta-
tions in leptin (LEP) and leptin receptor (LEPR) gene are asso-
ciated with obesity in rodents and humans (4-6). Also, leptin 
affects the balance of cytokines in the feto-placental unit (7), 
and therefore the pregnancy outcome (8,9). Also, leptin syn-
thesized in the placenta acts through binding to leptin re-
ceptors, which are expressed in the trophoblast (10,11).
Previous research has shown that genetic variability in ma-
ternal LEP and LEPR gene might be involved in pathologi-
cal processes in pregnancy, including preeclampsia and 
gestational diabetes mellitus (12,13), while the role of the 
LEP and LEPR gene in the IRSA has not been investigated. 
Therefore, we hypothesized that maternal genetic variabil-
ity of the LEP and LEPR genes was associated with IRSA. For 
this purpose we performed a case-control genetic associa-
tion study of polymorphic sites in these two genes on a 
population of patients with IRSA in comparison with popu-
lation of women with two or more live births and no his-
tory of pathologic pregnancies.
MAterIALs And MetHods
Participants
The study included 323 women. The IRSA group consist-
ed of 178 women (consecutive patients) with a history of 
three or more spontaneous abortions of unknown etiol-
ogy before the 22nd week of gestation. The median of age 
was 33 years (range, 23 to 46) in the IRSA group and 34 
years (range, 20 to 48) in controls. All patients had normal 
karyotypes and no history of endocrine, metabolic, auto-
immune, or other systemic disorders, venous or arterial 
thrombosis, or uterine anatomic abnormalities. The con-
trol group consisted of 145 women with at least two nor-
mal pregnancies and no pregnancy loss or any other preg-
nancy related complications. The miscarriages were not 
investigated cytogenetically. Participants were of Cauca-
sian origin, recruited at the Department of Obstetrics and 
Gynecology, Clinical Hospital Center Osijek, and the Clini-
cal Institute of Medical Genetics, Division of Obstetrics and 
Gynecology, University Medical Center, Ljubljana, Slovenia 
from 2010 till 2012 (Table 1). The study was approved by 
Slovenian and Croatian National Ethics’ Committees, and 
each of the patients provided written informed consent.
single nucleotide polymorphisms (snPs) selection and 
genotyping
We genotyped genetic variants in LEP and LEPR gene. 
Eight tagging SNPs were chosen, four SNPs in LEP gene 
– rs7799039, rs2122627, rs10244329, and rs11761556 and 
four SNPs in LEPR gene – rs12062820, rs1186403, rs1137101, 
and rs7516341. We based the selection on the known ge-
netic linkage in both genes, according to HapMap Phase 3 
genetic linkage information (http://www.hapmap.org). The 
SNPs were regarded as proxies for neighboring SNPs, when 
their pairwise r2 values exceeded 0.80. The set of most rep-
resentative tagSNPs for LEP and LEPR gene regions was ob-
tained using the Tagger algorithm available through the 
Haploview software (version 4.2) (14). To maximize statisti-
cal power, only the SNPs with minor allele frequency val-
ues exceeding 0.05 were analyzed.
Genomic DNA was isolated from the peripheral blood 
samples using QIAamp DNA Mini Kit (Qiagen, Hilden, Ger-
many). SNPs genotyping was carried out by real time poly-
merase chain reaction (PCR) method on 7000 Sequence 
Detection System (Applied Biosystems, Foster City, CA, 
USA) using KASPar SNP genotyping chemistry (KBiosci-
ence Ltd, Hoddesdon, United Kingdom), which is based on 
allele-specific PCR amplification. The reactions were per-
formed in accordance with manufacturer’s protocol. The 
tABLe 1. Characteristics of patients with idiopathic recurrent 
spontaneous abortion (IrsA)
IrsA
Age (years), median (range)  33 (23-46)
Parity, n (%)
0 118 (66.3)
1  45 (25.3)
2  15 (8.4)
spontaneous abortions, n (%)
3 162 (91)
4   8 (4.5)
5   7 (3.9)
10   1 (0.5)
duration of gestation, n (%)
first trimester 162 (91.9)
second trimester  12 (8.1)
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allelic discrimination analysis was performed using SDS 
Software Version 1.2 (Applied Biosystems). Genotype as-
signment was performed and interpreted independently 
by two investigators.
statistical analysis
All calculations and statistical analyses were carried out in 
R statistical environment (R version 2.15.0, available from: 
http://cran.r-project.org/). Hardy-Weinberg test was used 
for normality testing. Where appropriate, the P values were 
adjusted for multiple testing, according to Bonferroni. Only 
the values exceeding the threshold of 0.05 after correction 
for multiple testing were considered significant. Relation-
ships between genotype information and disease affec-
tion status were initially investigated separately for each 
SNP. Here, significance of association was estimated using 
χ2 test, and odds ratio values (OR) with 95% confidence 
intervals (CI) were calculated using functions in the gap 
package for R (http://cran.r-project.org/web/packages/
gap/index.html). Associations were considered significant 
when the P value was <0.05.
Our genotype distribution was compared with those pre-
dicted by the Hardy-Weinberg equilibrium using χ2 good-
ness-of-fit test, as additional level of genotyping quality 
control. As the study participants were not related, haplo-
type reconstruction was done in silico using software tools 
for haplotype prediction. When referring to haplotypes, 
we considered the definition of haplotypes as a set of vari-
ants present in block on the same chromosome. We used 
SNPs to define specific haplotypes for both LEP and LEPR 
gene. Each haplotype is labeled as the sequence of alleles 
captured in the selected haplotype. As an example – we 
shortened the naming for haplotype in LEPR gene with 
rs1137101-G/rs7516341-T/rs1186403-C/rs12062820-C al-
lele combination to GTCC. Haplotype frequencies and their 
associations with disease IRSA status were analyzed using 
haplo.stats statistical package (http://mayoresearch.mayo.
edu/mayo/research/schaid_lab/software.cfm), which cal-
culates indirectly measured haplotypes, under the as-
sumption that study participants are not related and link-
age phase is unknown. Only haplotypes with simulated 
frequencies below 0.05 were used in downstream analyses. 
Corrections for multiple testing were performed according 
to Benjamini Hochberg false discovery rate approach.
We estimated the power of our study to detect variations 
with low effect size. The power of detecting a significant 
result in the presence of actual genotype-phenotype ef-
fect with genotype relative risk equal to at least 2.0, was 
86%, when taking into account the sample size included, 
significance threshold of 0.05, prevalence of IRSA in gen-
eral population equal to 0.01, disease allele frequency of at 




Genotype frequencies of investigated polymorphisms 
in both the study and control group were in accordance 
with those predicted by the Hardy-Weinberg equilibrium 
(P > 0.05). Genotype and allelic distribution of the LEP and 
LEPR polymorphisms are shown in Table 2.
tABLe 2. Genotype and allelic distribution of leptin (LeP) and leptin receptor (LePr) polymorphisms of patients with and without 
idiopathic recurrent spontaneous abortion (IrsA)
Genotype frequencies




















rs7799039 A 0.40 0.46 0.16 0.534 0.86 0.54-1.37 0.099 1.58 0.92-2.77
rs21226227 T 0.08 0.98 0.42 0.805 1.22 0.18-10.66 0.422 0.78 0.42-1.43
rs11761556 C 0.45 0.42 0.52 0.714 0.90 0.51-1.59 0.504 1.17 0.73-1.90
rs10244329 A 0.46 0.50 0.37 0.886 0.96 0.58-1.61 0.173 1.45 0.85-2.51
LEPR
rs1137101 A 0.48 0.54 0.09 0.472 0.83 0.50-1.39 0.048 1.66 1.00-2.80
rs7516341 C 0.33 0.40 0.05 0.034 0.61 0.38-0.97 0.354 1.40 0.68-3.00
rs1186403 C 0.28 0.23 0.10 0.315 1.26 0.80-2.00 0.082 0.51 0.23-1.10
rs12062820 T 0.18 0.18 1.00 0.657 0.79 0.26-2.39 0.847 0.95 0.59-1.54
*Minor allele frequency.
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We found a higher allele frequency for rs7516341 (P = 0.052) 
in LEPR gene in the IRSA group. Also, the IRSA group 
had more frequent genotype distribution of rs7516341 
(P = 0.034, OR 0.61, 95% CI 0.38-0.97) and rs1137101 
(P = 0.048, OR 1.66, 95% CI 1.00-2.80) in LEPR gene. After ad-
justment for multiple testing according to Bonferroni, dif-
ferences in allele and genotype frequencies failed to reach 
adjusted significance threshold. We did not find any sig-
nificant association between rs12062820 and rs1186403 
polymorphisms in LEPR, as well as rs7799039, rs2122627, 
rs10244329, and rs11761556 polymorphisms in LEP gene 
and IRSA.
Haplotype analyses at LeP and LePr loci
We identified 4 inferred haplotypes in LEP gene and 6 in-
ferred haplotypes in the LEPR gene – the haplotypes iden-
tified are denoted with corresponding allele of the inter-
rogated SNP (Table 3). Simulated P values reflecting the 
difference in haplotype frequency distribution are also pre-
sented. Haplotypes with frequency below 5% in the set of 
all cases were excluded from downstream analyses.
In patients with IRSA, GTCC haplotype in the LEPR gene 
locus was significantly less frequent (P = 0.00865, OR 0.45) 
than ACTC haplotype (P = 0.0087, OR 1.98) in comparison 
to controls. We did not find a significant difference in the 
frequencies of the 4 most frequent haplotypes for the 4 
analyzed SNPs in the LEP gene between the study and con-
trol group.
dIsCussIon
We showed that genetic variability in the LEPR gene was 
associated with IRSA. LEP and LEPR expression in various 
maternal tissues, placenta, and fetal tissues suggests the 
physiologic and pathophysiologic significance of leptin 
and leptin receptors in normal pregnancy (15-17). The re-
lationship between LEPR expression and a successful em-
bryo implantation has been shown by Allegra et al (18). 
They showed that LEPR may have a role in embryo-mater-
nal cross-talk during the implantation window; endometri-
al LEPR expression was lower in patients with implantation 
failure. Also, previous studies reported significantly lower 
leptin concentrations in women who miscarried than in 
those with successful pregnancy, suggesting that leptin 
may play a role in preventing miscarriage (19-22). Lep-
tin is capable of influencing placental nutrient transport, 
crucial for fetal growth regulation (23). Placental villi frag-
ments have functional leptin receptors, which stimulates 
the system A of placental aminoacid transport through 
Janus kinase and signal transducer and activator of tran-
scription proteins signaling pathway. Placental amino ac-
ids transport is reduced in pregnancies with fetal growth 
retardation (24,25). Genetic variability in the LEP and LEPR 
gene was previously associated with susceptibility to obe-
sity and obesity-related metabolic diseases (26,27). The link 
between maternal obesity and pregnancy complications, 
including the risk of recurrent miscarriage, has also been 
reported (3). Furthermore, women with the LEPR 223A/G 
or 223G/G genotypes had an increased risk of develop-
ing severe preeclampsia compared with women with the 
223A/A genotype, whereas 2548 G/A LEP polymorphism 
was associated with gestational diabetes mellitus (12,13). 
These polymorphisms are connected either with inad-
equate signaling capacity of leptin receptor and suscep-
tibility to development of leptin resistance or with low 
leptin expression (due to mutation in gene promoter) 
and consequently low leptin response. Chin et al (28) 
failed to demonstrate any significant association of 
tABLe 3. Frequencies and distribution of probable haplotypes in patients with and without idiopathic recurrent spontaneous abor-
tion (IrsA) as predicted by haplo.stats
rs7799039 rs2122627 rs11761556 rs10244329 Frequency in patients Frequency in controls simulated P
G T C A 0.05019 0.07931 0.26533
G C C T 0.33186 0.36897 0.32593
G C A T 0.12048 0.14254 0.35734
A C A A 0.40024 0.38284 0.68377
rs1137101 rs7516341 rs1186403 rs12062820 Frequency in patients Frequency in controls simulated P
G T C C 0.05682 0.12851 0.0087
G T T C 0.21407 0.22973 0.3936
A T T T 0.11096 0.13368 0.500
G C C C 0.13213 0.11630 0.82219
A T T C 0.18268 0.16895 0.3940
A C T C 0.16275 0.09096 0.0146
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those polymorphisms in the LEPR and LEP gene with recur-
rent pregnancy loss. The polymorphisms investigated in 
our study are either in intron (rs7516341) or coding region 
(rs1137101) of LEPR gene and both can be connected with 
inefficient response to circulating leptin levels.
One of the limitations of our study is that, considering the 
number of samples surveyed, we attained sufficient power 
to detect only associations with larger effects (with effect 
size greater than 2.0), while association of variants with mi-
nor effects might have been missed. Another potential lim-
itation lies in the SNP selection, which was aimed to cap-
ture most of the contributing genetic variation. We may 
still have missed rare functional polymorphisms or poly-
morphisms out of linkage with those tested in our study, 
particularly those in LEP gene. Also, we lacked the cytoge-
netic data on miscarried fetuses and polymorphism of fetal 
LEP and LEPR genes. Mutations in down-stream genes of 
fetal leptin signaling pathway are another possible patho-
logic mechanism behind RSA, but this was not assessed in 
our study. We also did not address the possibility of trans-
placental transport of maternal leptin and interaction with 
fetal leptin receptor, which might be further complicated 
by polymorphism on either side of interaction.
In conclusion, this study showed that genetic variability in 
the LEPR gene was associated with IRSA. Additional genet-
ic association studies on a larger number of IRSA patients, 
as well as evaluation of other LEPR and LEP genetic varia-
tions, are necessary to elucidate the role of leptin signaling 
pathway in IRSA.
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